Jason Bacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jason Bacher has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Yilmaz
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
1 shared publication - Benjamin J. Swanson
Department of Pathology, Microbiology, and Immunology, The University of Nebraska Medical Center, Omaha, NE 68198, USA
1 shared publication - Christopher Bigley
Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
1 shared publication - Heather Hampel
Division of Clinical Cancer Genomics, City of Hope, Duarte, CA
1 shared publication - Joshua F. Coleman
Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA
1 shared publication - Kristin Miller
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
1 shared publication
Latest Publications
- Open Access
- 2 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 205
Instability in Pentanucleotide Markers in a Subset of Microsatellite Instability-High Colorectal Cancer
Microsatellite instability (MSI) testing is frequently used to screen patients for the early detection of Lynch syndrome, the most common hereditary colorectal cancer syndrome. MSI testing compares microsatellite repeat lengths in tumor DNA with those in matched normal tissue from the same patient. Therefore, precise sample identification is critical for obtaining reliable test results. The Penta-C and Penta-D pentanucleotide markers are widely used for sample identification in MSI testing. We investigated instability, defined as allelic mismatches or shifts, discordant fragment sizes, or the appearance of alleles in tumor DNA that were absent in the corresponding normal DNA, in the Penta-C and Penta-D loci across 2609 paired colorectal tumor and matched normal tissue or blood DNA samples. The allele sizes of both markers did not match in 0.3% of microsatellite-stable (MSS) and 12.3% of microsatellite instability-high (MSI-H) patients (p < 0.001, difference in proportions, 12.0% (95% CI, 8.9–15.1%)). Non-matching allele sizes in 12.3% of the MSI-H tumors suggest that other repeat markers may also be unstable and not suitable for sample identification in these tumors.
- 2 April 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 205
Open AccessInstability in Pentanucleotide Markers in a Subset of Microsatellite Instability-High Colorectal Cancer
Microsatellite instability (MSI) testing is frequently used to screen patients for the early detection of Lynch syndrome, the most common hereditary colorectal cancer syndrome. MSI testing compares microsatellite repeat lengths in tumor DNA with those in matched normal tissue from the same patient. Therefore, precise sample identification is critical for obtaining reliable test results. The Penta-C and Penta-D pentanucleotide markers are widely used for sample identification in MSI testing. We investigated instability, defined as allelic mismatches or shifts, discordant fragment sizes, or the appearance of alleles in tumor DNA that were absent in the corresponding normal DNA, in the Penta-C and Penta-D loci across 2609 paired colorectal tumor and matched normal tissue or blood DNA samples. The allele sizes of both markers did not match in 0.3% of microsatellite-stable (MSS) and 12.3% of microsatellite instability-high (MSI-H) patients (p < 0.001, difference in proportions, 12.0% (95% CI, 8.9–15.1%)). Non-matching allele sizes in 12.3% of the MSI-H tumors suggest that other repeat markers may also be unstable and not suitable for sample identification in these tumors.